Search
for
Sort by
Research 31–60 of 174
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Skin steroidogenesis in health and disease
- Study of<i>Demodex</i>mites: Challenges and Solutions
- Hair loss in children in South-East Nigeria: common and uncommon cases
- Transepidermal UV radiation of scalp skin <i>ex vivo</i> induces hair follicle damage that is alleviated by the topical treatment with caffeine
- The Association Between Low Grade Systemic Inflammation and Skin Diseases: A Cross-sectional Survey in the Northern Finland Birth Cohort 1966
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–like Autoimmune Disease
- Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Characterization of X‐linked hypohidrotic ectodermal dysplasia (XL‐HED) hair and sweat gland phenotypes using phototrichogram analysis and live confocal imaging
- An intergenerational androgenic mechanism of female intrasexual competition in the cooperatively breeding meerkat
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Gene Expression Profiling of the Intact Dermal Sheath Cup of Human Hair Follicles
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Heterogeneity in amount of growth factors secreted by platelets in platelet‐rich plasma samples from alopecia patients
- Androgenetic Alopecia
- Significance of iron status in hair loss in women
- The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease